These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 9600478

  • 1. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women.
    Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, Shah AS, Anderson PW.
    JAMA; 1998 May 13; 279(18):1445-51. PubMed ID: 9600478
    [Abstract] [Full Text] [Related]

  • 2. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar 13; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 3. Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.
    Christodoulakos GE, Lambrinoudaki IV, Panoulis CP, Papadias CA, Kouskouni EE, Creatsas GC.
    Gynecol Endocrinol; 2004 May 13; 18(5):244-57. PubMed ID: 15346660
    [Abstract] [Full Text] [Related]

  • 4. Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.
    Anderson PW, Cox DA, Sashegyi A, Paul S, Silfen SL, Walsh BW.
    Maturitas; 2001 Jul 25; 39(1):71-7. PubMed ID: 11451623
    [Abstract] [Full Text] [Related]

  • 5. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul 25; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 6. Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study.
    de Valk-de Roo GW, Stehouwer CD, Meijer P, Mijatovic V, Kluft C, Kenemans P, Cohen F, Watts S, Netelenbos C.
    Arterioscler Thromb Vasc Biol; 1999 Dec 25; 19(12):2993-3000. PubMed ID: 10591680
    [Abstract] [Full Text] [Related]

  • 7. Raloxifene lowers serum lipoprotein(A) in healthy postmenopausal women: a randomized, double-blind, placebo-controlled comparison with conjugated equine estrogens.
    Mijatovic V, van der Mooren MJ, Kenemans P, de Valk-de Roo GW, Netelenbos C.
    Menopause; 1999 Dec 25; 6(2):134-7. PubMed ID: 10374220
    [Abstract] [Full Text] [Related]

  • 8. Effects of endurance exercise and hormone replacement therapy on serum lipids in older women.
    Binder EF, Birge SJ, Kohrt WM.
    J Am Geriatr Soc; 1996 Mar 25; 44(3):231-6. PubMed ID: 8600189
    [Abstract] [Full Text] [Related]

  • 9. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec 25; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 10. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.
    JAMA; 1995 Jan 18; 273(3):199-208. PubMed ID: 7807658
    [Abstract] [Full Text] [Related]

  • 11. A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.
    Reid IR, Eastell R, Fogelman I, Adachi JD, Rosen A, Netelenbos C, Watts NB, Seeman E, Ciaccia AV, Draper MW.
    Arch Intern Med; 2004 Apr 26; 164(8):871-9. PubMed ID: 15111373
    [Abstract] [Full Text] [Related]

  • 12. Individual and combined effects of estrogen/progestin therapy and lovastatin on lipids and flow-mediated vasodilation in postmenopausal women with coronary artery disease.
    Herrington DM, Werbel BL, Riley WA, Pusser BE, Morgan TM.
    J Am Coll Cardiol; 1999 Jun 26; 33(7):2030-7. PubMed ID: 10362210
    [Abstract] [Full Text] [Related]

  • 13. Treatment with hormone replacement therapy lowers remnant lipoprotein particles in healthy postmenopausal women: results from a randomized trial.
    Ossewaarde ME, Dallinga-Thie GM, Bots ML, van der Schouw YT, Rabelink TJ, Grobbee DE, Westerveld HT.
    Eur J Clin Invest; 2003 May 26; 33(5):376-82. PubMed ID: 12713450
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular effects of droloxifene, a new selective estrogen receptor modulator, in healthy postmenopausal women.
    Herrington DM, Pusser BE, Riley WA, Thuren TY, Brosnihan KB, Brinton EA, MacLean DB.
    Arterioscler Thromb Vasc Biol; 2000 Jun 26; 20(6):1606-12. PubMed ID: 10845879
    [Abstract] [Full Text] [Related]

  • 15. Effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolism.
    Lobo RA, Bush T, Carr BR, Pickar JH.
    Fertil Steril; 2001 Jul 26; 76(1):13-24. PubMed ID: 11438314
    [Abstract] [Full Text] [Related]

  • 16. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E.
    JAMA; 1998 Aug 19; 280(7):605-13. PubMed ID: 9718051
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
    Hernández E, Valera R, Alonzo E, Bajares-Lilue M, Carlini R, Capriles F, Martinis R, Bellorin-Font E, Weisinger JR.
    Kidney Int; 2003 Jun 19; 63(6):2269-74. PubMed ID: 12753317
    [Abstract] [Full Text] [Related]

  • 19. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
    Godsland IF.
    Fertil Steril; 2001 May 19; 75(5):898-915. PubMed ID: 11334901
    [Abstract] [Full Text] [Related]

  • 20. The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease.
    Sbarouni E, Kyriakides ZS, Kremastinos DTh.
    J Am Coll Cardiol; 1998 Nov 19; 32(5):1244-50. PubMed ID: 9809932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.